Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Therapy
Studies in the area of breast cancer therapy reported from University of California
February 1st, 2007
Scientists discuss in "Predicting chemotherapy response to paclitaxel with 18F-Fluoropaclitaxel and PET" new findings in breast cancer. "Paclitaxel is used as a chemotherapy drug for the treatment of various malignancies, including breast, ovarian, and lung cancers. To evaluate the potential of a noninvasive prognostic tool for specifically predicting the resistance of tumors to paclitaxel therapy, we examined the tumoral uptake of (18)F-fluoropaclitaxel ((18)F-FPAC) in mice bearing human breast cancer xenografts by using small-animal-dedicated PET and compared (18)F-FPAC uptake with the tumor response to paclitaxel treatment," investigators in the United States report. ...
Source: Women's Health Weekly (2007-02-01)
|
|
Advertisement |
|
|
|
